Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

137.00 

3.20 2.4%

as of May 21 '19

52 Week Range:

111.60 151.40


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates through Ypsomed Diabetes Care, Ypsomed Delivery Systems, and Others segments. The Ypsomed Delivery Systems segment offers various injection systems, such as pen injectors, auto injectors, and dual-chamber pens, as well as insulin pens, other diabetes pens, pens for growth hormones, and other pens. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The Others segment offers precision turned parts. In addition, it offers contract manufacturing and other services. The company markets its products through biotechnology and pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, other European countries, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18
Earnings BIT 5.00
16.00
26.95
44.25
55.28
60.87
growth rate 220.0% 68.4% 64.2% 24.9% 10.1%
Avg.PE 55.72
55.46
35.90
growth rate -0.5% -35.3%
Balance Sheet Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18
Acct.Receivable 31.00
35.00
45.44
52.80
63.73
98.64
growth rate 12.9% 29.8% 16.2% 20.7% 54.8%
Acct.Payable 17.00
16.00
15.48
19.97
21.96
31.92
growth rate -5.9% -3.2% 29.0% 10.0% 45.4%
Cur.Assets 109.00
115.00
123.50
148.36
175.38
218.31
growth rate 5.5% 7.4% 20.1% 18.2% 24.5%
Total Assets 342.00
355.00
361.21
388.87
421.80
500.24
growth rate 3.8% 1.8% 7.7% 8.5% 18.6%
Cash 10.00
16.00
16.24
25.51
38.88
32.11
growth rate 60.0% 1.5% 57.0% 52.4% -17.4%
Inventory 57.00
52.00
51.78
49.10
48.32
59.28
growth rate -8.8% -0.4% -5.2% -1.6% 22.7%
Cur.Liabilities 101.00
103.00
100.63
105.33
103.01
142.45
growth rate 2.0% -2.3% 4.7% -2.2% 38.3%
Liabilities 124.00
126.00
120.57
121.04
120.01
158.70
growth rate 1.6% -4.3% 0.4% -0.9% 32.2%
LT Debt 20.00
20.00
15.00
10.00
10.00
10.00
growth rate 0.0% -25.0% -33.3% 0.0% 0.0%
Equity 240.64
267.84
301.80
341.54
growth rate 11.3% 12.7% 13.2%
Common Shares 179.00
179.00
178.99
178.99
178.99
178.99
growth rate 0.0% 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18
Capital Expenditures 16.00
19.00
17.21
25.15
27.48
51.03
growth rate 18.8% -9.4% 46.1% 9.3% 85.7%
Cash Dividends 3.78
7.58
12.61
16.41
growth rate 100.2% 66.5% 30.1%
Cash From OA 15.00
41.00
41.38
76.69
75.06
53.27
growth rate 173.3% 0.9% 85.3% -2.1% -29.0%
Sale Purchase of Stock 1.12
1.38
1.38
growth rate 23.6% 0.0%
FCF -1.00
22.00
24.17
51.53
47.58
2.24
growth rate 100.0% 9.9% 113.2% -7.7% -95.3%
Income Statement Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18
Sales 245.00
276.00
306.63
336.92
389.56
466.12
growth rate 12.7% 11.1% 9.9% 15.6% 19.7%
Op.Income 5.00
16.00
26.95
44.25
55.28
60.87
growth rate 220.0% 68.4% 64.2% 24.9% 10.1%
IBT 23.73
43.20
55.39
61.95
growth rate 82.0% 28.2% 11.8%
Net Income 2.00
14.00
19.40
35.81
46.25
52.06
growth rate 600.0% 38.5% 84.7% 29.1% 12.6%
Gross Profit 57.00
71.00
85.85
103.19
125.48
139.83
growth rate 24.6% 20.9% 20.2% 21.6% 11.4%

Quarterly Statements

Item Name Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Earnings BIT 13.47
16.97
16.97
34.18
34.18
growth rate 26.0% 0.0% 101.5% 0.0%
Balance Sheet Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Acct.Receivable 72.56
98.64
98.64
63.26
63.26
growth rate 35.9% 0.0% -35.9% 0.0%
Acct.Payable 27.43
31.92
31.92
17.81
17.81
growth rate 16.3% 0.0% -44.2% 0.0%
Cur.Assets 185.10
218.31
218.31
221.39
221.39
growth rate 17.9% 0.0% 1.4% 0.0%
Total Assets 440.56
500.24
500.24
547.23
547.23
growth rate 13.6% 0.0% 9.4% 0.0%
Cash 35.45
32.11
32.11
35.02
35.02
growth rate -9.4% 0.0% 9.1% 0.0%
Inventory 53.99
59.28
59.28
49.91
49.91
growth rate 9.8% 0.0% -15.8% 0.0%
Cur.Liabilities 121.40
142.45
142.45
154.06
154.06
growth rate 17.3% 0.0% 8.2% 0.0%
Liabilities 136.75
158.70
158.70
170.95
170.95
growth rate 16.1% 0.0% 7.7% 0.0%
LT Debt 10.00
10.00
10.00
10.00
10.00
growth rate 0.0% 0.0% 0.0% 0.0%
Equity 303.81
341.54
341.54
376.28
376.28
growth rate 12.4% 0.0% 10.2% 0.0%
Common Shares 178.99
178.99
178.99
178.99
178.99
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Capital Expenditures 10.47
15.05
15.05
29.52
29.52
growth rate 43.8% 0.0% 96.2% 0.0%
Cash Dividends 8.20
8.82
8.82
8.82
8.82
growth rate 7.6% 0.0% 0.0% 0.0%
Cash From OA 15.71
10.92
10.92
27.10
27.10
growth rate -30.5% 0.0% 148.1% 0.0%
Sale Purchase of Stock 3.52
3.52
3.52
growth rate 0.0% 0.0%
FCF 5.25
-4.13
-4.13
-2.42
-2.42
growth rate -100.0% 0.0% 0.0% 0.0%
Income Statement Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Sales 106.68
126.38
126.38
129.35
129.35
growth rate 18.5% 0.0% 2.4% 0.0%
Op.Income 13.47
16.97
16.97
34.18
34.18
growth rate 26.0% 0.0% 101.5% 0.0%
IBT 13.65
17.33
17.33
32.24
32.24
growth rate 26.9% 0.0% 86.1% 0.0%
Net Income 11.70
14.33
14.33
28.04
28.04
growth rate 22.5% 0.0% 95.7% 0.0%
Gross Profit 30.85
39.06
39.06
55.06
55.06
growth rate 26.6% 0.0% 40.9% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

E (27.97)

YOY Growth Grade:

D (39.23)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 20.15 20.35
EPS / Growth 6.73

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 12.8%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 12.8% 12.8% 12.8%
Future PE 0.01 15.27 15.27
Future EPS 22.49 22.49 22.49
Value Price
MOS %
0.06
-100.0%
84.86
-38.1%
84.86
-38.1%
MOS Price 0.03 42.43 42.43
IRT 9.93 9.93 9.93

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.